Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of efferocytosis in neuro-degenerative diseases.
Taheri F, Taghizadeh E, Navashenaq JG, Rezaee M, Gheibihayat SM. Taheri F, et al. Among authors: navashenaq jg. Neurol Sci. 2022 Mar;43(3):1593-1603. doi: 10.1007/s10072-021-05835-6. Epub 2022 Jan 21. Neurol Sci. 2022. PMID: 35059903 Review.
Macrophage: A Key Therapeutic Target in Atherosclerosis?
Taghizadeh E, Taheri F, Renani PG, Reiner Ž, Navashenaq JG, Sahebkar A. Taghizadeh E, et al. Among authors: navashenaq jg. Curr Pharm Des. 2019;25(29):3165-3174. doi: 10.2174/1381612825666190830153056. Curr Pharm Des. 2019. PMID: 31470780 Review.
MicroRNAs and Efferocytosis: Implications for Diagnosis and Therapy.
Mahmoudi A, Moadab F, Safdarian E, Navashenaq JG, Rezaee M, Gheibihayat SM. Mahmoudi A, et al. Among authors: navashenaq jg. Mini Rev Med Chem. 2022;22(20):2641-2660. doi: 10.2174/1389557522666220330150937. Mini Rev Med Chem. 2022. PMID: 35362375 Review.
CRISPR: A Promising Tool for Cancer Therapy.
Mohammad-Rafiei F, Safdarian E, Adel B, Vandchali NR, Navashenaq JG, Gheibihayat SM. Mohammad-Rafiei F, et al. Among authors: navashenaq jg. Curr Mol Med. 2023;23(8):748-761. doi: 10.2174/1566524022666220624111311. Curr Mol Med. 2023. PMID: 35748558 Review.
Effect of diabetes on efferocytosis process.
Mahmoudi A, Firouzjaei AA, Darijani F, Navashenaq JG, Taghizadeh E, Darroudi M, Gheibihayat SM. Mahmoudi A, et al. Among authors: navashenaq jg. Mol Biol Rep. 2022 Nov;49(11):10849-10863. doi: 10.1007/s11033-022-07725-2. Epub 2022 Jul 28. Mol Biol Rep. 2022. PMID: 35902446 Review.
Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials.
Salmaninejad A, Ilkhani K, Marzban H, Navashenaq JG, Rahimirad S, Radnia F, Yousefi M, Bahmanpour Z, Azhdari S, Sahebkar A. Salmaninejad A, et al. Among authors: navashenaq jg. Curr Pharm Des. 2021;27(28):3161-3169. doi: 10.2174/1381612827666210426100206. Curr Pharm Des. 2021. PMID: 33902409 Review.
Interleukin-22 in human inflammatory diseases and viral infections.
Shabgah AG, Navashenaq JG, Shabgah OG, Mohammadi H, Sahebkar A. Shabgah AG, et al. Among authors: navashenaq jg. Autoimmun Rev. 2017 Dec;16(12):1209-1218. doi: 10.1016/j.autrev.2017.10.004. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037907 Review.
48 results